行情

VIVE

VIVE

Viveve Medical
NASDAQ

实时行情|Nasdaq Last Sale

0.9401
-0.0798
-7.82%
盘后: 0.9400 -0.0001 -0.01% 17:15 01/24 EST
开盘
1.020
昨收
1.020
最高
1.020
最低
0.8769
成交量
20.81万
成交额
--
52周最高
5.40
52周最低
0.8769
市值
996.75万
市盈率(TTM)
-0.2070
分时
5日
1月
3月
1年
5年
医疗技术报告将 Viveve 监管主管列为医疗器械领域 25 位女性领导者之一
Viveve SVP Suzon Lommel named to list for second consecutive year for efforts to advance innovative technologies to treat stress urinary incontinence in womenENGLEWOOD, CO / ACCESSWIRE / January 13, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical tech...
ACCESSWIRE · 01/13 13:28
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 2021/12/20 13:08
Viveve Announces Completion Of Full Enrollment In Pivotal U.S. PURSUIT Trial For Stress Urinary Incontinence
Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it has completed enrollment in its pivotal PURSUIT clinical trial to assess the efficacy and
Benzinga · 2021/12/14 13:34
Viveve Medical Q3 EPS $(0.67) Misses $(0.61) Estimate, Sales $1.60M Miss $1.69M Estimate
Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.61) by 9.84 percent. This is a 157.69 percent decrease over losses of $(0.26) per share from
Benzinga · 2021/11/11 21:11
Viveve Medical EPS misses by $0.10, misses on revenue
Viveve Medical (NASDAQ:VIVE): Q3 GAAP EPS of -$0.67 misses by $0.10. Revenue of $1.6M (+5.3% Y/Y) misses by $0.09M. Press Release
Seekingalpha · 2021/11/11 21:04
-- Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.6M, vs. Street Est of $1.69M
MT Newswires · 2021/11/11 16:19
Viveve Medical 2021 年第三季度收益预览
Viveve Medical (NASDAQ:VIVE) is scheduled to announce Q3 earnings results on Thursday, November 11th, after market close. The consensus EPS Estimate is -$0.57 (-119.2% Y/Y) and the consensus Revenue Estimate
Seekingalpha · 2021/11/10 22:35
Notable earnings after Thursday's close
ACHR, AEYE, AGRO, DADAAQN, ARRY, ASTR, AVGR, AVIR, BEEM, BLFS, BLNK, OTCPK:BOWFF, CODX, CPNG, OTCPK:EIFZF, FLO, GAN, GOVX, GP, HYFM, OTCQB:IGXT, INTZ, INUV, JAMF, JOBY, LAZR, LTRX, MAPS, OTC:NWHUF, ONTX,
Seekingalpha · 2021/11/10 22:35
更多
财务预测
实际值(万 美元)
预测值(万 美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解VIVE最新的财务预测,通过VIVE每股收益,每股净资产,每股现金流等数据分析Viveve Medical近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

50.00%强力推荐
50.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测VIVE价格均价为9.63,最高价位10.75,最低价为8.50。
最高10.75
均价9.63
最低8.50
现价0.9401
EPS
实际EPS
预期EPS
-2.08-1.56-1.04-0.52
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 45
机构持股: 1,798.14万
持股比例: 169.59%
总股本: 1,060.26万
类型机构数股数
增持
4
3.72万
建仓
4
5.62万
减持
3
7,377
平仓
3
8.49万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-0.50%
医疗设备和用品
-0.18%
高管信息
Non-Executive Chairman/Independent Director
Steven Basta
Chief Executive Officer/Director
Scott Durbin
Senior Vice President
Jim Robbins
Director
Deborah Jorn
Independent Director
Arlene Morris
Independent Director
Sharon Presnell
暂无数据
VIVE 简况
Viveve Medical Inc于2016年5月10日注册成立,从事设计、开发、制造和销售平台医疗技术,即低温冷却单极射频(CMRF)。该公司的CMRF技术通过射频(RF)发生器、手机和治疗提示,统称为Viveve系统。 Viveve系统在市场上用于阴道口松弛、性功能、阴道年轻化和压力性尿失禁(SUI)的非侵入性治疗,这被称为Viveve治疗。Viveve系统使用一种传送单极射频能量来治疗组织的方法,例如单极射频能量。 Viveve系统还使用冷冻剂表面冷却,可以对阴道组织进行体积加热。该治疗有助于通过在尿道膀胱颈周围再生胶原蛋白来稳定尿道潜在的过度活动。该公司的子公司包括Viveve, Inc.和Viveve BV。

微牛提供Viveve Medical Inc(NASDAQ-VIVE)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的VIVE股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易VIVE股票基本功能。